BeStock  
Stocks › Biotechnology › MLTX

MoonLake Immunotherapeutics MLTX

US equityMarket cap rank #3298Biotechnology
$10.77 −$0.18 (-1.64%)
Pre-market · Oct 8, 8:50 am ET · After hours $10.96 +1.76%
Open$10.81
Prev close$10.95
Day range$10.71 – $11.29
Volume1.40M
Market cap$916.60M
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q2, ended Jun 2026

Revenue$0.00
Operating profit-$61.66M-1.6% YoY
Net profit-$61.81M-10.3% YoY
Diluted EPS-$0.84+3.4% YoY
Free cash flow-$55.56M-1.9% YoY
Operating cash flow-$55.56M

Revenue, last 8 quarters

$0.0Sep '24$0.0Dec '24$0.0Mar '25$0.0Jun '25$0.0Sep '25$0.0Dec '25$0.0Mar '26$0.0Jun '26

Net profit, last 8 quarters

$-36.1MSep '24$-46.4MDec '24$-40.6MMar '25$-56.1MJun '25$-70.7MSep '25$-63.0MDec '25$-69.7MMar '26$-61.8MJun '26

Diluted EPS by quarter

-0.56Sep '24-0.72Dec '24-0.63Mar '25-0.87Jun '25-1.10Sep '25-0.92Dec '25-0.98Mar '26-0.84Jun '26

Free cash flow by quarter

$-25.4MSep '24$-48.6MDec '24$-38.2MMar '25$-54.5MJun '25$-44.5MSep '25$-58.8MDec '25$-66.3MMar '26$-55.6MJun '26

Annual revenue

$0.0FY22$0.0FY23$0.0FY24$0.0FY25

Profitability & balance sheet

Return on equity-67.4%
Return on assets-51.0%
Return on invested capital-53.7%
Current ratio12.56
Liabilities / assets25.4%
Cash & investments$537.03M
Total debt$100.29M
Net cash (debt)$436.74M

Income statement

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Operating Revenue $0.00 $0.00 $0.00 $0.00 $0.00
Operating Expense $61.66M $70.02M $244.83M $65.22M $71.43M
Selling and Admin Expenses $11.44M $15.51M $41.97M $9.21M $10.80M
-General & Admin Expense $11.44M $15.51M $41.97M $9.21M $10.80M
Research & Development $50.22M $54.52M $202.86M $56.01M $60.64M
Operating Profit -$61.66M -$70.02M -$244.83M -$65.22M -$71.43M
Net Non-Operating Interest Income (Expense) -$2.63M -$2.27M -$7.25M -$1.99M -$3.20M
Non-Operating Interest Expense $2.63M $2.27M $7.25M $1.99M $3.20M
Other Income (Expense) $2.58M $3.21M $22.37M $4.44M $4.05M
Gain on Sale of Security -$294,000.00 – – – –
Other Non-Operating Income (Expenses) $2.87M $3.21M $22.37M $4.44M $4.05M
Pretax Profit -$61.72M -$69.09M -$229.71M -$62.77M -$70.58M
Tax $90,000.00 $622,000.00 $611,000.00 $248,000.00 $115,000.00
Net Profit -$61.81M -$69.71M -$230.32M -$63.02M -$70.69M
Profit from Continuing Operations -$61.81M -$69.71M -$230.32M -$63.02M -$70.69M
Minority Interests $0.00 $0.00 -$3.00M -$591,000.00 -$965,000.00
Net Income to Parent Company -$61.81M -$69.71M -$227.32M -$62.43M -$69.73M
Net Income to Common Stockholders -$61.81M -$69.71M -$227.32M -$62.43M -$69.73M
Basic EPS -$0.84 -$0.98 -$3.53 -$0.92 -$1.10
Diluted EPS -$0.84 -$0.98 -$3.53 -$0.92 -$1.10

Balance sheet

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Assets $573.95M $400.37M $424.43M $424.43M $414.34M
Total Current Assets $570.04M $396.64M $421.69M $421.69M $411.22M
Cash and Cash Equivalents & Short-Term Investments $537.03M $357.92M $393.97M $393.97M $380.48M
-Cash and Cash Equivalents $477.91M $298.49M $334.52M $334.52M $350.74M
-Short Term Investments $59.13M $59.43M $59.45M $59.45M $29.74M
Receivables $6.56M $5.76M $4.87M $4.87M $4.02M
-Other Receivables $6.56M $5.76M $4.87M $4.87M $4.02M
Prepaid Assets $26.45M $32.96M $22.86M $22.86M $26.71M
Total Non-Current Assets $3.91M $3.73M $2.74M $2.74M $3.12M
Net PPE $2.57M $2.39M $2.14M $2.14M $2.53M
-Gross PPE $2.57M $2.39M $2.14M $2.14M $2.53M
Other Non-Current Assets $1.34M $1.34M $596,000.00 $596,000.00 $587,000.00
Total Liabilities $145.75M $146.35M $119.95M $119.95M $123.14M
Total Current Liabilities $45.39M $46.11M $45.48M $45.48M $48.37M
Payables $19.38M $24.78M $30.65M $30.65M $26.30M
-Accounts Payable $17.04M $23.38M $28.43M $28.43M $23.82M
-Total Tax Payable $2.35M $1.40M $1.09M $1.09M $1.01M
Current Accrued Expenses $22.15M $18.22M $11.27M $11.27M $16.37M
Short-Term Debt and Capital Lease Obligation $1.25M $920,000.00 $1.23M $1.23M $1.50M
-Current Capital Lease Obligation $1.25M $920,000.00 $1.23M $1.23M $1.50M
Total Non-Current Liabilities $100.36M $100.24M $74.47M $74.47M $74.78M
Long Term Debt and Capital Lease Obligation $100.29M $99.88M $74.47M $74.47M $74.23M
-Long Term Debt $99.51M $99.02M $74.10M $74.10M $73.74M
-Long Term Capital Lease Obligation $772,000.00 $865,000.00 $374,000.00 $374,000.00 $486,000.00
Employee Benefits $74,000.00 $353,000.00 $0.00 $0.00 $549,000.00
Total Equity $428.20M $254.02M $304.48M $304.48M $291.19M
Stockholders' Equity $428.20M $254.02M $304.48M $304.48M $288.91M
Capital Stock $8,000.00 $7,000.00 $7,000.00 $7,000.00 $6,000.00
-Common Stock $8,000.00 $7,000.00 $7,000.00 $7,000.00 $6,000.00
Additional Paid-In Capital $1.02B $786.31M $766.78M $766.78M $689.11M
Retained Earnings -$594.42M -$532.62M -$462.91M -$462.91M -$400.49M
Gains/Losses Not Affecting Retained Earnings $630,000.00 $322,000.00 $604,000.00 $604,000.00 $278,000.00
-Other Payable – – $1.13M $1.13M $1.46M
Minority Interests – – $0.00 $0.00 $2.29M

Cash flow

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Operating Cash Flow -$55.56M -$66.29M -$196.01M -$58.79M -$44.54M
Net cash flow from continuing operations -$55.56M -$66.29M -$196.01M -$58.79M -$44.54M
Net Income from Continuing Operations -$61.81M -$69.71M -$230.32M -$63.02M -$70.69M
Gain/Loss from Continuing Operations $9,000.00 $11,000.00 -$58,000.00 -$31,000.00 -$18,000.00
Depreciation & Depletion & Amortization $896,000.00 $845,000.00 $2.62M $751,000.00 $745,000.00
Other Non-Cash Items $19,000.00 $422,000.00 -$1.02M -$92,000.00 $283,000.00
Change in Working Capital $2.78M -$11.21M $19.88M $6,000.00 $21.43M
-Change in Receivables -$798,000.00 -$894,000.00 -$2.03M -$847,000.00 -$612,000.00
-Change in Prepaid Assets $6.51M -$10.10M $561,000.00 $3.86M $274,000.00
-Change in Payables and Accrued Expense -$2.55M $950,000.00 $23.15M -$2.63M $21.06M
-Change in Other Current Assets $9,000.00 -$779,000.00 -$587,000.00 $0.00 $1.11M
-Change in Other Current Liabilities -$395,000.00 -$389,000.00 -$1.22M -$377,000.00 -$401,000.00
Net cash flow from investing $322,000.00 $98,000.00 $202.99M -$29.91M $88.40M
Net Cash Flow from Continuing Investing Activities $322,000.00 $98,000.00 $202.99M -$29.91M $88.40M
Net PPE Purchase and Sale $0.00 $0.00 -$35,000.00 $0.00 $0.00
Net Investment Purchase and Sale $322,000.00 $98,000.00 $203.03M -$29.91M $88.40M
Financing Cash Flow $234.62M $30.64M $146.00M $72.40M $480,000.00
Net Cash Flow from Continuing Financing Activities $234.62M $30.64M $146.00M $72.40M $480,000.00
Net Issuance Payments Of Debt $0.00 $24.47M $73.02M $0.00 $0.00
Net Common Stock Issuance $234.07M $6.01M $72.40M $72.40M $0.00
Proceeds from Stock Option Exercised $551,000.00 $170,000.00 $580,000.00 $0.00 $480,000.00
Ending Cash Balance $477.91M $298.49M $334.52M $334.52M $350.74M
Net Change in Cash $179.39M -$35.54M $152.98M -$16.31M $44.34M
Beginning Cash Balance $298.49M $334.52M $180.43M $350.74M $306.68M
Effect of Exchange Rate Changes $29,000.00 -$483,000.00 $1.11M $91,000.00 -$285,000.00
Free Cash Flow -$55.56M -$66.29M -$196.04M -$58.79M -$44.54M

Discussion

No comments yet — be the first to weigh in on MLTX.

Leave a comment

Scroll to Top